55965-63-4C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(OCCO)c(OCCO)c4)oc4cc(OCCO)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1OIYVFNTXFRYQLRP-VVSTWUKXSA-NTroxerutin has been used in trials studying the treatment of Chronic Venous Insufficiency.
55965-63-4、7085-55-4DTXSID4045929CHEMBL3182320安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
This chemical does not meet GHS hazard criteria for 70.8% (63 of 89) of all reports.
Warning
H302 (29.2%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 89 reports by companies from 3 notifications to the ECHA C&L Inventory.
Chemical: 4H-1-Benzopyran-4-one, 2-[3,4-bis(2-hydroxyethoxy)phenyl]-3-[[6-O-(6-deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl]oxy]-5-hydroxy-7-(2-hydroxyethoxy)-
Troxerutin: Does not have an individual approval but may be used under an appropriate group standard
C05CA04
C - Cardiovascular system
QC - Cardiovascular system
現在のフィルター条件では反応記録がありません。
読み込み中…